Summary Tumour cells exposed to hypoxia in vitro can show increased expression of several selected genes, including the gene encoding the vascular endothelial growth factor (VEGF), suggesting that hypoxia followed by reoxygenation might promote the malignant progression of tumours. An in vitro/in vivo study was conducted to investigate whether hypoxia can increase the angiogenic potential of tumour cells through increased VEGF secretion. Four human melanoma cell lines (A-07, D-12, R-18, U-25) were included in the study. Cell cultures were exposed to hypoxia (oxygen concentration <10 p.p.m.) in vitro using the steel chamber method. Rate of VEGF secretion was measured in vitro in aerobic and hypoxic cell cultures by ELISA. Angiogenesis was assessed in vivo using the intradermal angiogenesis assay. Aliquots of cells harvested from aerobic cultures or cultures exposed to hypoxia for 24 h were inoculated intradermally in the flanks of adult female BALB/cnu/nu mice. Tumours developed and angiogenesis was quantified by scoring the number of capillaries in the dermis oriented towards the tumours. The number of tumour-oriented capillaries did not differ significantly between tumours from hypoxic and aerobic cultures for A-07 and U-25, whereas tumours from hypoxic cultures showed a larger number of tumour-oriented capillaries than tumours from aerobic cultures for D-1 2 and R-1 8. The VEGF secretion under aerobic conditions and the absolute increase in VEGF secretion induced by hypoxia were lower for D-12 and R-18 than for A-07 and U-25, whereas the relative increase in VEGF secretion induced by hypoxia was higher for D-12 and R-18 than for A-07 and U-25. VEGF is not a limiting factor in the angiogenesis of some tumours under normoxic conditions. Hypoxia can increase the angiogenic potential of tumour cells by increasing the secretion of VEGF, but only of tumour cells showing low VEGF secretion under normoxia. Transient hypoxia might promote the malignant progression of tumours by temporarily increasing the angiogenic potential of tumour cells showing low VEGF expression under normoxic conditions. Keywords: angiogenesis; hypoxia; melanoma; vascularization; VEGF Many malignant tumours develop regions of hypoxic cells during growth (Coleman, 1988; Vaupel et al, 1989; Brown and Giaccia, 1994) . Two types of hypoxia have been recognized: chronic hypoxia, arising from limitations in oxygen diffusion, and acute hypoxia, resulting from transient stoppages in microregional blood flow (Stone et al, 1993; Horsman, 1995) . Reoxygenation of hypoxic cells occurs during unperturbed tumour growth as a result of reopening of temporarily closed vessels and during therapy as a result of therapy-induced tumour cell inactivation (Kallman, 1972; Brown, 1979; Chaplin et al, 1987) . Hypoxia followed by reoxygenation might promote the malignant progression of tumours (Hill, 1990) . Thus, tumour cells exposed to hypoxia in vitro can show increased expression of several selected genes, including genes encoding cell cycle-regulatory proteins, haematopoietic and/or vascular regulatory proteins, metastasis-promoting proteins, viral proteins, metabolic enzymes and transcription factors (Brown and Giaccia, 1994; Dachs and Stratford, 1996) . Hypoxia-response elements governing the increased gene expression in response to hypoxia have been discovered in the vicinity of most of these genes (Dachs and Stratford, 1996) . Moreover, tumour cells subjected to transient hypoxia in vitro can show increased metastatic potential in vivo (Young and Hill, 1988) and
Many malignant tumours develop regions of hypoxic cells during growth (Coleman, 1988; Vaupel et al, 1989; Brown and Giaccia, 1994) . Two types of hypoxia have been recognized: chronic hypoxia, arising from limitations in oxygen diffusion, and acute hypoxia, resulting from transient stoppages in microregional blood flow (Stone et al, 1993; Horsman, 1995) . Reoxygenation of hypoxic cells occurs during unperturbed tumour growth as a result of reopening of temporarily closed vessels and during therapy as a result of therapy-induced tumour cell inactivation (Kallman, 1972; Brown, 1979; Chaplin et al, 1987) . Hypoxia followed by reoxygenation might promote the malignant progression of tumours (Hill, 1990) . Thus, tumour cells exposed to hypoxia in vitro can show increased expression of several selected genes, including genes encoding cell cycle-regulatory proteins, haematopoietic and/or vascular regulatory proteins, metastasis-promoting proteins, viral proteins, metabolic enzymes and transcription factors (Brown and Giaccia, 1994; Dachs and Stratford, 1996) . Hypoxia-response elements governing the increased gene expression in response to hypoxia have been discovered in the vicinity of most of these genes (Dachs and Stratford, 1996) . Moreover, tumour cells subjected to transient hypoxia in vitro can show increased metastatic potential in vivo (Young and Hill, 1988) and increased resistance to some chemotherapeutic agents (Rice et al, 1987; Luk et al, 1990; Sanna and Rofstad, 1994) . Exposure of tumour cells to transient hypoxia in vitro can also induce cell subpopulations showing a slightly increased DNA content (Rice et al, 1986; Wilson et al, 1989) or a doubling of the number of chromosomes (Rofstad et al, 1996) . Finally, clinical studies have indicated that tumours showing low oxygen tensions or high lactate concentrations may have a higher metastatic potential than tumours showing high oxygen tensions or low lactate concentrations (Schwickert et al, 1995; Brizel et al, 1996; Hockel et al, 1996; Walenta et al, 1997) .
Tumour angiogenesis plays an important role in the progression of malignant diseases (Folkman, 1985) . Thus, angiogenesis is necessary for a tumour to grow beyond a certain size, given by the diffusion distances of oxygen and other nutrients (Folkman, 1990) . The process of angiogenesis is also a critical determinant of the growth rate of primary tumours and the development of metastases (Fidler and Ellis, 1994) . Tumour angiogenesis is regulated by several stimulatory and inhibitory angiogenic factors (Folkman and Klagsbrun, 1987) . The stimulatory angiogenic factor that presently receives the greatest attention is the vascular endothelial growth factor (VEGF) (Hlatky et al, 1996) . VEGF, a 45-kDa heparinbinding glycoprotein dimer existing in four different isoforms (VEGF 121165,189,206) arising from alternative m-RNA splicing, is a specific endothelial cell mitogen (Zagzag, 1995) . Some xenografted tumours established from cell lines transfected with VEGF show increased vascular density and metastatic frequency relative to non-transfected control tumours  897 Potgens et al, 1996) . Northern and Western blot analyses have shown that VEGF can be up-regulated in tumour cells exposed to hypoxia in vitro (Shweiki et al, 1995; Waleh et al, 1995) . Tumour cells adjacent to necrotic regions can show increased VEGF expression, as revealed by in situ hybridization (Plate et al, 1992; Shweiki et al, 1992) . It is therefore possible that tumour hypoxia causes increased angiogenesis through increased VEGF synthesis and secretion, and hence promotes malignant progression. The purpose of the work reported here was to test this hypothesis. Cells from four human melanoma cell lines differing in angiogenic potential were exposed to hypoxia in vitro. VEGF secretion was measured in vitro by ELISA and angiogenesis was assessed in athymic nude mice using the intradermal angiogenesis assay.
MATERIALS AND METHODS Cell lines
Four human melanoma cell lines (A-07, D-12, R-18, U-25) were included in the study (Rofstad, 1994) . The cell lines were maintained in monolayer culture in RPMI 1640 medium (25 mM HEPES and L-glutamine) supplemented with 13% fetal calf serum, 250 mg 1-' penicillin and 50 mg 1-' streptomycin. The cultures were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air and subcultured twice a week by trypsinization (treatment with 0.05% trypsin/0.02% EDTA solution at 37°C for 2 min). The cell lines were verified to be free from Mycoplasma contamination using the Hoechst fluorescence and the mycotrin methods (Chen, 1977) .
Hypoxia exposure
Monolayer cell cultures growing in glass dishes were exposed to hypoxia using the steel chamber method (Sanna and Rofstad, 1994) . The cultures were incubated at 37°C in a humidified atmosphere of 5% carbon dioxide in air for 24 h before the hypoxia treatment. The culture medium was removed and replaced by fresh medium immediately before the cells were exposed to hypoxia. The medium used during the hypoxia treatment was supplemented with 2.2 g 1-1 sodium bicarbonate. The pH of the medium was 7.4 ± 0.1. The glass dishes were kept in air-tight steel chambers during the hypoxia treatment. The medium layer covering the cells was approximately 2 mm in thickness. The steel chambers were flushed with a humidified, highly purified gas mixture consisting of 95% nitrogen and 5% carbon dioxide at a flow rate of 5 1 min-m.
Measurements showed that the concentration of oxygen in the medium was less than 10 p.p.m. after 30 min of flushing. Control cultures were flushed with humidified 5% carbon dioxide in air. After the hypoxia treatment, the cells were detached from the glass dishes by trypsinization and washed in Ca2+-and Mg2+-free Hanks' balanced salt solution (HBSS and V is the volume of medium. The second factor of this product is based on the assumption that the cell number increased exponentially with time during At, an assumption that was verified to be fulfilled for aerobic control cultures. There was no significant cell proliferation under hypoxic conditions, i.e. the second factor of the product was -1 for hypoxic cultures. Replicate cell cultures were used to determine N.. Cell numbers were counted using a haemocytometer and a phase-contrast microscope.
Angiogenesis
Angiogenic potential was assessed in vivo using the intradermal angiogenesis assay (Kreisle and Ershler, 1988; Runkel et al, 1991) . Adult female BALB/c-nu/nu mice, bred at our research institute, were used as test animals. The mice were maintained under pathogen-free conditions at constant temperature (24-26°C) and humidity (30-50%). Sterilized food and tap water were given ad libitum. Animal care was in accord with institutional guidelines. Cells were harvested from aerobic control cultures or cultures exposed to hypoxia for 24 h. Aliquots of the cells, suspended in 10 ,ul of Ca2+-and Mg2+-free HBSS, were inoculated intradermally in the flanks of mice using a 100-gl Hamilton syringe (Rofstad, 1994) . The skin around the inoculation sites was removed at predetermined times after the inoculation when small tumours had developed. The tumours were located with a dissecting microscope, and angiogenesis was quantified by counting the capillaries oriented towards the tumours (Rofstad, 1994) . The number of capillaries was corrected for the background, determined after injection of 10 gl of HBSS. The tumours were dissected free from the skin and weighed after the tumour oriented capillaries had been scored. (Altman, 1991) . All P-values were determined from two-sided tests. A significance criterion of P < 0.05 was used. The statistical analysis was performed using SigmaStat statistical software (Jandel Scientific, Erkrath, Germany).
RESULTS
Inoculation of tumour cells evoked a strong angiogenic response in the mouse dermis. Capillaries oriented towards the inoculum were formed, and after a few days depending on the cell line and the number of cells inoculated, the new capillaries penetrated the inoculum and a small vascularized tumour arose. The number of capillaries oriented towards a tumour increased with the time after inoculation (data not shown). The angiogenic response was cell line dependent. This is illustrated in Figure 1 , which shows the number of tumour-oriented capillaries at day 7 after the inoculation of 3. In Figure 2 , the angiogenic response evoked by cells from cultures exposed to a 24-h hypoxia treatment is compared with that evoked by cells from aerobic control cultures. The plot shows the number of tumour-oriented capillaries vs the number of cells per inoculum. The cells were inoculated immediately after the hypoxia treatment and the capillaries were scored at day 5 (A-07), day 7 (D-12) or day 14 (R-18, U-25) after the inoculation. The time interval from cell inoculation to capillary scoring was varied because the rate of angiogenesis differed among the cell lines. The number of capillaries did not differ between tumours from hypoxic cultures and those from aerobic cultures for A-07 (P > 0.05) and U-25 (P > 0.05). In contrast, tumours from hypoxic cultures showed a larger number of capillaries than tumours from aerobic cultures for D-12 (P < 0.0005) and R-18 (P < 0.005).
Figure 3 refers to the same experiments as Figure 2 and shows tumour weight vs the number of cells per inoculum. The weight did not differ between tumours from hypoxic cultures and those from aerobic cultures for A-07 (P > 0.05) and U-25 (P > 0.05). In contrast, cells from hypoxic cultures gave rise to larger tumours than cells from aerobic cultures for D-12 (P < 0.001) and R-18 (P < 0.005). The similarities in Figures 2 and 3 suggest that the weight of the tumours was closely related to the angiogenic response evoked by the cell inocula. In fact, there was a strong correlation between tumour weight and the number of tumouroriented capillaries for each cell line (P < 0.0001) (data not shown). The rate of VEGF secretion in vitro differed among the cell lines (Figure 4) . A-07 showed a higher secretion rate than U-25 (P < 0.05), which in turn showed a higher secretion rate than D-12 and R-18 (P < 0.05), under both aerobic and hypoxic conditions. The secretion rates were higher for hypoxic cultures than for aerobic control cultures for all four cell lines (P < 0.001 for D-12, R-18 and U-25; P < 0.05 for A-07). The mean values for hypoxic cultures were higher than those for aerobic cultures by factors of approximately 1.5 (A-07), 7 (D-12), 10 (R-18) and 4 (U-25). D-12 and R-18, which had the lowest secretion rates under aerobic conditions, showed the highest relative increases in secretion rate induced by hypoxia. However, the absolute increases in VEGF secretion induced by hypoxia were lower for D-12 and R-18 than for A-07 and U-25 (Figure 4 ).
DISCUSSION
Direct evidence that hypoxia can promote tumour angiogenesis has not been published so far. However, it has been hypothesized that the development of hypoxic regions in tumours leads to increased angiogenesis through increased synthesis and secretion of VEGF (Claffey and Robinson, 1996; Hlatky et al, 1996) . Several angiogenic factors can be involved in tumour angiogenesis (Folkman and Klagsbrun, 1987) , and the hypothesis is based on the assumptions that tumour angiogenesis is limited by the concentration of VEGF and that hypoxia can increase VEGF synthesis and secretion to an extent that is sufficient to increase tumour angiogenesis. The following observations support the hypothesis. Tumour cells exposed to hypoxia in vitro can show increased levels of VEGF m-RNA and protein (Shweiki et al, 1995; Waleh et al, 1995) . The VEGF expression in multicellular spheroids and solid tumours is usually enhanced in regions believed to be hypoxic (Plate et al, 1992; Shweiki et al, 1992 Shweiki et al, , 1995 Waleh et al, 1995) . VEGF has been shown to be a specific endothelial cell mitogen in vitro (Gospodarowicz et al, 1989) . Two high-affinity VEGF receptors (flt-I and KDR) have been recognized on human endothelial cells (de Vries et al, 1992; Terman et al, 1992) . The expression of VEGF is correlated to vascular density in several histological types of human tumours (Guidi et al, 1995; Takahashi et al, 1995; Toi et al, 1995; Mattern et al, 1996) . Experimental tumours transfected with VEGF can show a higher vascular density and volumetric growth rate than wild-type control tumours (Zhang et al, 1995; Potgens et al, 1996) , whereas tumours initiated from cells transfected with antisense-VEGF c-DNA can show reduced vascular density and growth in vivo (Saleh et al, 1996) . The neovascularization and growth of experimental tumours can be inhibited by treatment with monoclonal antibodies against VEGF (Kim et al, 1993; Asano et al, 1995; Melnyk et al, 1996) . Finally, VEGF increases microvascular permeability to macromolecules, thereby leading to fibrinogen extravasation and fibrin deposition, which are important processes in tumour angiogenesis (Senger et al, 1993) .
Detailed studies of hypoxia-induced tumour angiogenesis require the use of adequate experimental end points. Thus, the number of tumour-oriented capillaries, determined using the intradermal angiogenesis assay, was applied as end point for tumour angiogenesis in the present work. Many investigators use tumour vascular density as a measure of angiogenic potential. However, the vascular density of tumours is not only governed by the rate of neovascularization, as is the number of tumour-oriented capillaries at a given time after tumour cell inoculation. Other biological properties of tumours, such as the rates of cell proliferation and development of necrosis, have substantial influence on vascular density. Moreover, hypoxia-induced VEGF up-regulation was studied here by measuring the rate of VEGF secretion in units of pg 10 6 cells h-I in aerobic and hypoxic cell cultures. This end point is probably more relevant for the rate of neovascularization than the levels of VEGF m-RNA and protein determined by Northern and Western blot analyses. Studies in our laboratory have shown that the rate of VEGF secretion cannot be predicted from the cellular content of VEGF protein.
A-07, D-12, R-18 and U-25 differed substantially in rate of VEGF secretion under aerobic conditions. Oncogenic transformation of cells with activated forms of the ras oncogene has been shown to increase the expression of VEGF (Grugel et al, 1995; Rak et al, 1995; Mazure et al, 1996) . Flow cytometric analysis has shown that the constitutive level of ras protein is significantly higher in A-07 than in D-12, R-18 and U-25. The position of the ras protein bands in Western blots does not differ among the cell lines.
The study reported here is the first to establish a connection between hypoxia, tumour angiogenesis and hypoxia-induced VEGF up-regulation. The data on D-12 and R-18 show that tumour cells exposed to hypoxic conditions can have a higher angiogenic potential than aerobic tumour cells. Thus, the number of tumour-oriented capillaries was higher for tumours initiated from hypoxia-treated cultures than for tumours initiated from aerobic control cultures. Moreover, the tumours initiated from hypoxia-treated cultures were larger than the tumours initiated from control cultures, suggesting that the increased angiogenesis led to increased tumour growth. The increases in the number of tumour-oriented capillaries and the tumour weight were probably a consequence of increased VEGF secretion. The rate of VEGF secretion was higher for hypoxic cultures than for aerobic cultures by factors of approximately 7 (D-12) and 10 (R-1 8).
Northern blot analyses have shown that hypoxia-induced VEGF up-regulation decreases with time after reoxygenation (Hlatky et al, 1994) . Thus, VEGF was probably not up-regulated during the whole period from cell inoculation to capillary scoring in the tumours initiated from hypoxia-treated cultures. However, in D-12 and R-18, the tumours initiated from hypoxia-treated cultures might still have shown a higher rate of VEGF secretion during the whole period than the tumours initiated from control cultures, as they grew faster than the control tumours and thus, at similar times after cell inoculation, contained a larger number of secreting cells.
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It should also be noted that the cells derived from hypoxiatreated cultures were aerobic at the time of inoculation in athymic mice. The possibility thus exists that the experiments reported here underestimate the magnitude of hypoxia-induced angiogenesis. The time interval between the opening of the hypoxia chambers and the cell inoculation was kept as short as possible (<1 h) to minimize possible effects of reoxygenation.
The study reported here also suggests that exposure to hypoxia does not increase the angiogenic potential of the cells of all tumours. Thus, the A-07 and U-25 tumours did not show a higher number of tumour-oriented capillaries when initiated from hypoxia-treated cultures than when initiated from aerobic control cultures, despite the fact that the rate of VEGF secretion was higher for hypoxic cultures than for aerobic cultures by factors of approximately 1.5 (A-07) and 4 (U-25). The tumour weights did not differ significantly between the tumours initiated from hypoxia-treated cultures and the tumours initiated from aerobic cultures either.
Although the hypoxia-induced relative increases in VEGF secretion were lower for A-07 and U-25 cells than for D-12 and R-18 cells, the A-07 and U-25 cells showed the largest absolute increases. Consequently, the differences between the A-07 and U-25 cells and the D-12 and R-18 cells in hypoxia-induced angiogenesis cannot be attributed to differences in hypoxia-induced VEGF up-regulation. The differences between the A-07 and U-25 cells and the D-12 and R-18 cells are probably not a consequence of differences in angiogenic potential under aerobic conditions either, in that the sequence of the lines from high to low angiogenic potential was found to be: A-07, D-12, R-18, U-25 (Figure 1) .
The VEGF secretion data, however, offer a plausible explanation as to why exposure to hypoxia increased the angiogenic potential of the D-12 and R-18 cells but not of the A-07 and U-25 cells. The D-12 and R-18 cells showed lower rates of VEGF secretion under aerobic conditions than the A-07 and U-25 cells. It is therefore possible that the angiogenesis of control D-12 and R-18 tumours was limited by the rate of VEGF secretion. Hypoxiainduced VEGF up-regulation therefore led to increased angiogenesis. In contrast, the rate of VEGF secretion was probably not a limiting factor in the angiogenesis of control A-07 and U-25 tumours. Exposure to hypoxia therefore just led to secretion of redundant VEGF. It should be noticed that the VEGF secretion of the D-12 and R-18 cells under hypoxic conditions was similar to that of the U-25 cells under aerobic conditions. If our interpretation is correct, it can be concluded that (a) VEGF is not a limiting factor in the angiogenesis of some tumours under normoxic conditions and (b) the hypoxia-induced VEGF up-regulation in low VEGF-expressing tumour cells can be sufficiently large to eliminate VEGF as a limiting factor in the rate of neovascularization.
Tumours gradually develop aggressive phenotypic traits during growth, including the invasion of surrounding normal tissue and the dissemination of metastases. This process is termed the malignant progression of tumours and is probably a result of the genomic instability of tumour cells (Hill, 1990) . Recent studies have suggested that microenvironmental conditions known to occur in tumours, such as hypoxia and reoxygenation, might increase the genomic instability and hence promote the malignant progression (Hill, 1990; Brown and Giaccia, 1994; Dachs and Stratford, 1996; Hlatky et al, 1996) . The study reported here suggests that hypoxia might also promote the malignant progression by increasing the angiogenic potential of tumour cells through increased synthesis and secretion of VEGF. It should be noted, however, that hypoxia-induced VEGF up-regulation probably results in increased angiogenic potential only in tumour cells showing low VEGF expression under normoxic conditions. It should also be noted that hypoxia-induced VEGF up-regulation and the accompanying increased angiogenic potential is a transient phenomenon in acutely hypoxic cells; the VEGF expression probably returns gradually to normoxic levels after the reopening of temporarily closed vessels. However, a transient increase in the angiogenic potential of low VEGF-expressing tumour cells might be all that is required for some of the stages of the malignant progression of tumours, including some processes involved in the invasion of normal tissue and the dissemination of metastases.
